Rockville biotech begins human trials on lung cancer drug
EntreMed has launched a first round of human trials on lung cancer patients for a drug already in clinical tests to battle other forms of cancer.
The Rockville company is starting Phase I trials of MKC-1, its small-molecule drug to treat lung cancer — the same drug it began testing in Phase I for leukemia one month ago and in Phase II trials for advanced breast cancer 10 months ago.
This entry was posted on Thursday, October 26th, 2006 at 11:15 am and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.